Bio/Pharma News

Sep 07, 2017
By Pharmaceutical Technology Editors
With this acquisition, Merck gains a lead anti-tumor drug candidate and a proprietary technology that can potentially induce immediate and long-term anti-tumor immunity.
Sep 07, 2017
By Pharmaceutical Technology Editors
Merck KGaA completes the divestment of its biosimilars business as part of its strategy to focus on developing a pipeline of innovator drugs.
Sep 07, 2017
By Pharmaceutical Technology Editors
As Merck KGaA continues its strategic shift into a science and technology company, it is considering options for its Consumer Health business, including a potential sale.
Sep 06, 2017
By Pharmaceutical Technology Editors
Pfizer’s Mylotarg, an anti-body drug conjugate once voluntarily withdrawn, returns to the market under a new dosing regimen for treating leukemia.
Sep 05, 2017
By Pharmaceutical Technology Editors
Novartis has appointed Dr. Vasant Narasimhan as CEO.
Sep 01, 2017
By Pharmaceutical Technology Editors
With this acquisition, Oncurious, a Belgium-based biotechnology company, will gain a pipeline of immune-oncology drug candidates.
Sep 01, 2017
By Pharmaceutical Technology Editors
Bristol-Myers Squibb (BMS) and Daiichi Sankyo announced a collaboration to evaluate the combination of Opdivo (nivolumab) and antibody drug conjugate (ADC) DS-8201 for treating breast and bladder cancers.
Aug 31, 2017
By Pharmaceutical Technology Editors
Hospira, a Pfizer company, is voluntarily recalling one lot of vancomycin hydrochloride for injection, USP, 750 mg/vial because of glass within a single vial.
Aug 30, 2017
By Pharmaceutical Technology Editors
Genentech’s Actemra (tocilizumab), a rheumatoid arthritis drug, has been approved for a new indication, treating CAR T cell-induced cytokine release syndrome (CRS), a side effect of CAR T cell therapy.
Aug 30, 2017
By Pharmaceutical Technology Editors
FDA issued a Refusal to File letter to Acorda Therapeutics, citing insufficiently complete information in the company’s new drug application for its investigational Parkinson’s disease drug.
native1_300x100
lorem ipsum